Zanetti M, Filaci G, Lee R H, del Guercio P, Rossi F, Bacchetta R, Stevenson F, Barnaba V, Billetta R
Department of Medicine, University of California at San Diego, La Jolla 92093-0961.
EMBO J. 1993 Nov;12(11):4375-84. doi: 10.1002/j.1460-2075.1993.tb06122.x.
We report that an antibody engineered to express three Arg-Gly-Asp (RGD) repeats in the third complementarity-determining region of the heavy chain (antigenized antibody) efficiently inhibits the lysis of human erythroleukemia K-562 cells by natural killer (NK) cells. Synthetic peptides containing RGD did not inhibit. Inhibition was specific for the (RGD)3-containing loop and required simultaneous occupancy of the Fc receptor (CD16) on effector cells. The antigenized antibody inhibited other forms of cytotoxicity mediated by NK cells but not cytotoxicity mediated by major histocompatibility complex-restricted cytotoxic T lymphocytes (CTL). A three-dimensional model of the engineered antibody loop shows the structure and physicochemical characteristics probably required for the ligand activity. The results indicate that an RGD motif is involved in the productive interaction between NK and target cells. Moreover, they show that peptide expression in the hypervariable loops of an antibody molecule is an efficient procedure for stabilizing oligopeptides within a limited spectrum of tertiary structures. This is a new approach towards imparting ligand properties to antibody molecules and can be used to study the biological function and specificity of short peptide motifs, including those involved in cell adhesion.
我们报告称,一种经工程改造在重链的第三个互补决定区表达三个精氨酸-甘氨酸-天冬氨酸(RGD)重复序列的抗体(抗原化抗体)能有效抑制自然杀伤(NK)细胞对人红白血病K-562细胞的裂解。含RGD的合成肽并无抑制作用。抑制作用对含(RGD)3的环具有特异性,且需要效应细胞上的Fc受体(CD16)同时被占据。该抗原化抗体抑制了NK细胞介导的其他细胞毒性形式,但未抑制主要组织相容性复合体限制的细胞毒性T淋巴细胞(CTL)介导的细胞毒性。工程化抗体环的三维模型展示了可能是配体活性所需的结构和物理化学特征。结果表明,RGD基序参与了NK细胞与靶细胞之间的有效相互作用。此外,结果还表明,在抗体分子高变环中表达肽是在有限的三级结构范围内稳定寡肽的有效方法。这是一种赋予抗体分子配体特性的新方法,可用于研究短肽基序的生物学功能和特异性,包括那些参与细胞黏附的基序。